SBC Medical Group Holdings Incorporated SBCWW

FY2025 · ended Dec 31, 2025 · Revenue $173.61M, -15.5% YoY · Filed Mar 27, 2026

SBC Medical Group Holdings Incorporated (SBC) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $173.6 million and net income of $51.0 million. Free cash flow was $23.3 million. As of Jun 30, 2026 it held $185.9 million in cash and investments and $48.2 million in total debt.

Revenue (TTM)
$175.17M
Net income (TTM)
$49.03M
+47.1% vs year-ago TTM
Operating cash flow (TTM)
$62.82M
+821.8% vs year-ago TTM
Free cash flow (TTM)
$61.77M
EPS (TTM)
$0.48
Dividend per share
None
Shares outstanding
102.58M
+0.0% vs prior year
Net cash
$137.67M
as of Jun 30, 2026
Operating margin
37.3%
FY 2026

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
SBC (Nasdaq), SBCWW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1930313
Former names
Pono Capital Two, Inc. (until Aug 29, 2024)

Other Services-Offices & Clinics of Doctors of Medicine companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
Revenue
$173.6M
$205.4M
—
Operating income
$67.5M
$70.3M
$70.7M
Net income
$51.0M
$46.6M
$39.4M
Diluted EPS
$0.50
$0.48
—
Operating cash flow
$24.7M
$20.6M
$50.7M
Free cash flow
$23.3M
$18.0M
—
Total assets
$380.4M
$266.1M
$258.8M
Total liabilities
$117.1M
$71.1M
$115.0M
Stockholders' equity
$248.3M
$195.1M
$142.2M
Cash and investments
$164.1M
$128.1M
—
Total debt
$51.6M
$12.2M
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jul 14, 2026 Jul 8, 2026
ARS Annual report to shareholders May 28, 2026 Dec 31, 2025
8-K Current report
Officer or director change
May 20, 2026 May 14, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.